SMBC Group will be responsible for promoting widespread adoption of services based on this Alliance and enhancing value through the integration of healthcare and financial services. For the former, it will leverage digital touchpoints such as “Olive.” The Group has already begun offering “Olive Healthcare” based on its partnership with SoftBank in March 2026 and will further expand and develop this service. For the latter, in addition to promoting post-payment services at medical institutions, it aims to create services that provide both financial and health-related security and peace of mind.
Fujitsu will lead the development and management of the data platform, the creation of AI for healthcare institutions, and the development of next-generation computing resources and platforms necessary for innovative drug discovery and development activities using medical data. Fujitsu will leverage its top market share in medical data in Japan[ＨＬ1.1], as well as its healthcare-focused large language models from the “Takane” LLM lineup, its “Healthy Living Platform” for healthcare data utilization under the “Uvance” business model to solve societal issues, and its expertise in data governance, security, and sovereign cloud technologies that ensure data sovereignty.
SoftBank will lead the development and provision of domestically operated user apps leveraging sovereign cloud infrastructure and homegrown LLMs. It will utilize its extensive user base, including the “PayPay” ecosystem, “LINE,” and “Yahoo! JAPAN,” as well as its expertise in supporting health promotion for individuals, businesses, and municipalities in the healthcare sector. Through collaboration with healthcare providers and local governments, it aims to build highly convenient apps that enable users to access a wide range of services in one place.
SMBC Group, Fujitsu, and SoftBank will leverage their respective customer touchpoints to expand the use of the Japan-developed healthcare infrastructure to a scale of 60 million users, while aiming for adoption by 4,000 medical institutions. Through these efforts, the three companies will support the health of the population, assist the management of healthcare institutions, and contribute to the appropriate curbing of Japan’s healthcare costs. In doing so, they aim to further enhance the sustainability of Japan’s high-quality and widely accessible healthcare system.